Menu
Currency
GWAS Study

Genome-wide association study identifies an early onset pancreatic cancer risk locus.

Campa D, Gentiluomo M, Obazee O et al.

32270874 PubMed ID
GWAS Study Type
13259 Participants
50 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CD
Campa D
GM
Gentiluomo M
OO
Obazee O
BA
Ballerini A
VL
Vodickova L
HP
Hegyi P
SP
Soucek P
BH
Brenner H
MA
Milanetto AC
LS
Landi S
GX
Gao X
BD
Bozzato D
CG
Capurso G
TF
Tavano F
VY
Vashist Y
HT
Hackert T
BF
Bambi F
BS
Bursi S
OM
Oliverius M
GD
Gioffreda D
SB
Schöttker B
IA
Ivanauskas A
MB
Mohelnikova-Duchonova B
DE
Darvasi E
PR
Pezzilli R
ME
Małecka-Panas E
SO
Strobel O
GM
Gazouli M
KV
Katzke V
SA
Szentesi A
CG
Cavestro GM
FG
Farkas G
IJ
Izbicki JR
MS
Moz S
AL
Archibugi L
HV
Hlavac V
Vincze Á
TR
Talar-Wojnarowska R
RB
Rusev B
KJ
Kupcinskas J
GB
Greenhalf B
DF
Dijk F
GN
Giese N
BU
Boggi U
AA
Andriulli A
BO
Busch OR
VG
Vanella G
VP
Vodicka P
NM
Nentwich M
LR
Lawlor RT
TG
Theodoropoulos GE
JK
Jamroziak K
ZR
Zuppardo RA
ML
Moletta L
GL
Ginocchi L
KR
Kaaks R
NJ
Neoptolemos JP
LM
Lucchesi M
CF
Canzian F
Chapter II

Abstract

Summary of the research findings

Early onset pancreatic cancer (EOPC) is a rare disease with a very high mortality rate. Almost nothing is known on the genetic susceptibility of EOPC, therefore, we performed a genome-wide association study (GWAS) to identify novel genetic variants specific for patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) at younger ages. In the first phase, conducted on 821 cases with age of onset ≤60 years, of whom 198 with age of onset ≤50, and 3227 controls from PanScan I-II, we observed four SNPs (rs7155613, rs2328991, rs4891017 and rs12610094) showing an association with EOPC risk (P < 1 × 10-4 ). We replicated these SNPs in the PANcreatic Disease ReseArch (PANDoRA) consortium and used additional in silico data from PanScan III and PanC4. Among these four variants rs2328991 was significant in an independent set of 855 cases with age of onset ≤60 years, of whom 265 with age of onset ≤50, and 4142 controls from the PANDoRA consortium while in the in silico data, we observed no statistically significant association. However, the resulting meta-analysis supported the association (P = 1.15 × 10-4 ). In conclusion, we propose a novel variant rs2328991 to be involved in EOPC risk. Even though it was not possible to find a mechanistic link between the variant and the function, the association is supported by a solid statistical significance obtained in the largest study on EOPC genetics present so far in the literature.

821 European ancestry younger cases, 2,312 European ancestry older cases

Chapter III

Study Statistics

Key metrics and study information

13259
Total Participants
GWAS
Study Type
Yes
Replicated
2,385 European ancestry younger cases, 7,741 European ancestry older cases
Replication Participants
European
Ancestry
Czech Republic, Germany, Greece, Hungary, Italy, Lithuania, Netherlands, Poland, U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.